Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Asieris, Biogen, Biontech, Diffusion, Eisai, Enzychem Lifesciences, Fujifilm Kyowa Kirin, Immodulon, Merck, Mylan, Novartis, Otsuka, Pfizer, Propeller Health, Senhwa, Sosei.